Terminated EARLY_PHASE1 INTERVENTIONAL 2-arm NCT00708357

Does eNOS Gene Polymorphism Play a Role in the Maintenance of Basal Vascular Tone in the Choroid or Optic Nerve Head?

Sponsor: Medical University of Vienna

Conditions Ocular Physiology Regional Blood Flow

Updated 6 times since 2017 Last updated: Nov 14, 2014 Started: May 31, 2005 Primary completion: Dec 31, 2009 Completion: Jan 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from Medical University of Vienna

See all terminations from Medical University of Vienna

This EARLY_PHASE1 trial investigates Ocular Physiology and Regional Blood Flow and is currently terminated or withdrawn. Medical University of Vienna leads this study, which shows 6 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Terminated EARLY_PHASE1
Jan 2021 — Jul 2024 [monthly]

Terminated EARLY_PHASE1
Jun 2018 — Jan 2021 [monthly]

Terminated EARLY_PHASE1
Feb 2017 — Jun 2018 [monthly]

Terminated EARLY_PHASE1

Phase: Phase 0 → EARLY_PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Terminated Phase 0

First recorded

May 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medical University of Vienna

Data source: Medical University of Vienna

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Vienna, Austria